TREATMENT OF CANCER WITH NK CELLS AND A HER2 TARGETED ANTIBODY Application WO-2022216831-A1 World Intellectual Property Organisation (WIPO) 13 Oct 2022
TREATMENT OF CANCER WITH NK CELLS AND A CD38-TARGETED ANTIBODY Application WO-2022216826-A1 World Intellectual Property Organisation (WIPO) 13 Oct 2022
TREATMENT OF CANCER WITH NK CELLS AND A CD20 TARGETED ANTIBODY Application WO-2022216815-A1 World Intellectual Property Organisation (WIPO) 13 Oct 2022